FDA Approved: TYRUKO — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approved TYRUKO (natalizumab-sztn) from Sandoz Inc under an original Biologics License Application as a natalizumab biosimilar. The approval covers indicati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Multiple Sclerosis

Drugs mentioned

• TYRUKO (natalizumab-sztn)

Snippet

ORIG AP for TYRUKO (NATALIZUMAB-SZTN)